- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Established, Profitable and Undervalued
Global Pharmaceuticals & Biotech Established, Profitable and Undervalued
UPDATED Apr 23, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
50 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
A | US$139.20 | 3.5% | 4.6% | US$40.8b | US$150.51 | PE33x | E9.1% | 0.7% | ||
BIIB | US$193.18 | 0.5% | -32.9% | US$28.1b | US$290.83 | PE24.2x | E18.2% | n/a | ||
HZNP | US$116.30 | 0.06% | 82.8% | US$26.6b | US$116.50 | PE60.8x | E16.4% | n/a | ||
ICLR | US$306.45 | 4.9% | 52.6% | US$25.3b | US$352.79 | PE41.3x | E15.7% | n/a | ||
UCB | €121.75 | 1.5% | 42.8% | €23.1b | €122.71 | PE67.4x | E25.2% | 1.1% | ||
4578 | JP¥6,358.00 | 1.5% | 40.0% | JP¥3.5t | JP¥5,981.82 | PE28.4x | E6.8% | 1.9% | ||
600436 | CN¥224.90 | -1.2% | -15.8% | CN¥135.7b | CN¥290.29 | PE45.2x | E16.4% | 1.0% | ||
GMAB | kr.1,972.00 | -1.7% | -28.9% | kr.130.2b | kr.2,434.00 | PE29.4x | E21.7% | n/a | ||
BMRN | US$92.06 | 1.8% | -1.0% | US$17.5b | US$110.42 | PE104.2x | E30.9% | n/a | ||
AVTR | US$25.65 | 5.2% | 37.0% | US$17.4b | US$27.85 | PE54.3x | E27.2% | n/a | ||
4503 | JP¥1,469.00 | 0.2% | -26.2% | JP¥2.6t | JP¥2,056.25 | PE627.4x | E34.7% | 4.8% | ||
RPRX | US$27.82 | 0.8% | -20.7% | US$16.6b | US$45.40 | PE11x | E6.0% | 3.0% | ||
603259 | CN¥41.96 | -2.8% | -38.6% | CN¥118.5b | CN¥71.37 | PE12.8x | E9.7% | 2.3% | ||
SDZ | CHF30.59 | 9.0% | n/a | CHF13.1b | CHF35.11 | PE186.7x | E29.7% | 1.5% | ||
NBIX | US$140.09 | 5.1% | 36.4% | US$14.1b | US$153.55 | PE56.4x | E26.9% | n/a | ||
VTRS | US$11.36 | 2.3% | 24.8% | US$13.5b | US$12.40 | PE246.6x | E16.0% | 4.2% | ||
4507 | JP¥7,343.00 | 3.4% | 20.3% | JP¥2.1t | JP¥7,720.77 | PE13.5x | E-0.6% | 2.0% | ||
RVTY | US$103.50 | 2.9% | -20.2% | US$12.8b | US$123.24 | PE71.2x | E23.9% | 0.3% | ||
3692 | HK$16.80 | 6.5% | 15.4% | HK$99.5b | HK$18.89 | PE28.1x | E8.7% | 1.7% | ||
ERF | €61.60 | 4.5% | -0.06% | €11.9b | €60.00 | PE46.3x | E20.0% | 0.8% | ||
CRL | US$240.13 | 4.4% | 28.4% | US$12.3b | US$270.67 | PE26x | E11.4% | n/a | ||
BRKR | US$82.46 | -0.6% | 6.4% | US$12.0b | US$89.40 | PE28.1x | E2.5% | 0.2% | ||
INCY | US$51.65 | -2.0% | -29.8% | US$11.6b | US$75.20 | PE19.4x | E18.8% | n/a | ||
4523 | JP¥6,089.00 | 3.1% | -20.1% | JP¥1.7t | JP¥8,192.86 | PE38.4x | E13.2% | 2.6% |